SAN CLEMENTE, Calif., Aug. 21, 2025 (GLOBE NEWSWIRE) -- (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced its participation in the ...

As previously reported, Piper Sandler analyst Jason Bednar initiated coverage of ICU Medical (ICUI) with an Overweight rating and $145 price target The infusion pump market faced regulatory and ...

In a regulatory filing, ICU Medical (ICUI) disclosed that its CEO Vivek Jain bought 21.9K shares of common stock on August 14th in a total ...

ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended June 30, 2025.

The deal boosts the product line of ICU Medical, with a $4.4 billion market cap at press time. Like Smiths, it also focuses on developing devices or IV infusion therapy, including IV systems, ...

Calling ICU Medical’s subsequent pitch the “superior transaction,” Smiths expects to receive $1.85 billion in cash plus $500 million in ICU Medical shares, equal to about 10% of its extended ...

ICU Medical has recalled two lots of potassium chloride intravenous bags, citing a labeling problem that could lead users to overdose on the IV solution, according to an FDA notice posted Friday.

In trading on Wednesday, shares of ICU Medical, Inc. (NASD: ICUI) crossed above their 200 day moving average of $66.17, changing hands as high as $66.20 per share.

The mislabeled Potassium Chloride Inj. 20 mEq bags contain an overwrap label with Lot# 1023172 (NDC# 0990-7074-26) and an expiration date of 01-31-2026. ICU Medical is recalling 1 lot of Potassium ...

A recall of nearly 62,800 replacement batteries used in ICU Medical infusion pumps has received the FDA’s Class I rating—the agency’s most serious.

What happenedShares of ICU Medical (NASDAQ: ICUI), a medical device company specializing in intravenous treatment solutions, were on the move today following the announcement of a cash and stock ...